Edaravone is a free radical scavenger active pharmaceutical ingredient classified as a neuroprotective agent, supplied as a white to off-white crystalline powder for use in pharmaceutical formulations. It exerts its neuroprotective effect by neutralizing hydroxyl and peroxyl radicals, thereby reducing oxidative stress-induced damage to neuronal cell membranes and mitochondria, a mechanism particularly critical in conditions where acute oxidative injury drives disease progression.
Edaravone is indicated for use in formulations targeting acute ischemic stroke and amyotrophic lateral sclerosis (ALS), where it represents one of the few pharmacologically active agents with an approved therapeutic role in slowing functional decline. Its application in these high-scrutiny neurological indications places particular emphasis on API purity, batch consistency, and full regulatory traceability. The API is packaged in double LDPE bags within HDPE drums or equivalent pharma-grade, moisture-protective containers to maintain stability under recommended storage conditions.
As a leading distribution partner, Molkem Chemicals ensures reliable supply of products aligned with industry quality standards and regulatory expectations. Each product is delivered as per agreed specifications, supported by standard documentation including COA, SDS, and TDS. If required, our technical team can provide additional stability data and regulatory assistance.